These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21634007)

  • 1. Liver allocation and distribution: possible next steps.
    Washburn K; Pomfret E; Roberts J
    Liver Transpl; 2011 Sep; 17(9):1005-12. PubMed ID: 21634007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of public policies to procure and distribute kidneys for transplantation.
    Singer PA
    Arch Intern Med; 1990 Mar; 150(3):523-7. PubMed ID: 2178581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplant legislation: ethical and practical issues in liver allocation--The case of Switzerland.
    Kadry Z; Renner EL; Clavien PA
    Liver Transpl; 2001 Jul; 7(7):658-60. PubMed ID: 11460238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Model for End-Stage Liver Disease in the occurrence of infectious events and survival in a cohort of liver transplant recipients.
    Clemente WT; Romanelli RM; Faria LC; Lima SS; Jesus LA; Cortes JR; Sanches MD; Cançado OL; Lima AS
    Transplant Proc; 2013; 45(1):297-300. PubMed ID: 23375318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection.
    Freeman RB
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S2-3. PubMed ID: 15382218
    [No Abstract]   [Full Text] [Related]  

  • 7. The new liver allocation system: moving toward evidence-based transplantation policy.
    Freeman RB; Wiesner RH; Harper A; McDiarmid SV; Lake J; Edwards E; Merion R; Wolfe R; Turcotte J; Teperman L;
    Liver Transpl; 2002 Sep; 8(9):851-8. PubMed ID: 12200791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the first year of the new liver allocation plan.
    Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
    Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the use of donated cadaver livers: analysis and policy development to increase the application of split-liver transplantation.
    Emond JC; Freeman RB; Renz JF; Yersiz H; Rogiers X; Busuttil RW
    Liver Transpl; 2002 Oct; 8(10):863-72. PubMed ID: 12360426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based development of liver allocation: a review.
    Merion RM; Sharma P; Mathur AK; Schaubel DE
    Transpl Int; 2011 Oct; 24(10):965-72. PubMed ID: 21615548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global lessons in graft type and pediatric liver allocation: A path toward improving outcomes and eliminating wait-list mortality.
    Hsu EK; Mazariegos GV
    Liver Transpl; 2017 Jan; 23(1):86-95. PubMed ID: 27706890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.
    Shechter SM; Bryce CL; Alagoz O; Kreke JE; Stahl JE; Schaefer AJ; Angus DC; Roberts MS
    Med Decis Making; 2005; 25(2):199-209. PubMed ID: 15800304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to adult liver transplantation in Canada: a survey and ethical analysis.
    Mullen MA; Kohut N; Sam M; Blendis L; Singer PA
    CMAJ; 1996 Feb; 154(3):337-42. PubMed ID: 8564903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New organ allocation criteria and decreased mortality on liver transplant waiting list.
    Lang L
    Gastroenterology; 2008 Feb; 134(2):379-80. PubMed ID: 18242201
    [No Abstract]   [Full Text] [Related]  

  • 17. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K; Feng S
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waiting in line: should selected patients ever be moved up?
    Jonasson O
    Transplant Proc; 1989 Jun; 21(3):3390-4; discussion 3413-8. PubMed ID: 2662482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the lung allocation score.
    Takahashi SM; Garrity ER
    Semin Respir Crit Care Med; 2010 Apr; 31(2):108-14. PubMed ID: 20354924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time.
    Freeman RB; Rohrer RJ; Katz E; Lewis WD; Jenkins R; Cosimi AB; Delmonico F; Friedman A; Lorber M; O'Connor K; Bradley J
    Liver Transpl; 2001 Mar; 7(3):173-8. PubMed ID: 11244156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.